CLINICAL_TRIALS
trial_result
· 2020-10-22
Clinical Trial Update: Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D) [Phase 4]
Summary
Phase 4 trial investigating dapagliflozin and measures of cardiovascular autonomic function in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Type2 Diabetes, Cardiovascular Diseases | Phase 4 | Status: COMPLETED | Results posted: 2020-10-22